Transition report pursuant to Rule 13a-10 or 15d-10

STOCK-BASED COMPENSATION (Details Narrative)

v3.8.0.1
STOCK-BASED COMPENSATION (Details Narrative) - USD ($)
 10 Months Ended 12 Months Ended
Oct. 21, 2015
Dec. 31, 2017
Feb. 28, 2017
Jun. 29, 2016
Sep. 30, 2015
Common shares par value (in dollars per share)   $ 0.01 $ 0.01    
Independent Directors (Messrs. Radin, Anderson, Manko and Dr. Baker) [Member]          
Description of payment terms

Paid quarterly half in cash and half in common stock

        
Annually compensation paid per director $ 25,000        
Dr. Ma. [Member]          
Issuance of common stock   $ 129,019      
2015 Stock Option Plan [Member]          
Number of shares authorized       4,000,000 2,000,000
Number of common shares awarded   318,000 500,000    
Common shares par value (in dollars per share)         $ 0.01
Weighted average grant date fair value of stock options   $ 0.29 $ 0.21    
Allocated stock-based compensation expense   $ (4,417) $ 115,828    
Weighted-average grant-date fair value options granted   93,115 122,656    
Total intrinsic value of options exercised   0 0    
Total unrecognized compensation cost   $ 77,620      
Weighted-average period (in years)   17 months      
Total fair value of shares vested   $ 150,820 $ 98,432    
2015 Stock Option Plan [Member] | Key Employees [Member]          
Number of common shares awarded   1,038,000